In Brief: OncorMed/Endocrine Sciences
This article was originally published in The Gray Sheet
Executive Summary
OncorMed/Endocrine Sciences: Enter two-year distribution agreement, for undisclosed terms, under which Endocrine Sciences will distribute OncorMed's RET gene test for familial medullary thyroid carcinoma. Calabasas Hills, California-based Endocrine Sciences has the only U.S. sales force exclusively focused on selling diagnostic products to endocrinologists, the firm claims. OncorMed will perform the tests, provide client services, technical assistance, sales training and marketing and sales materials...